CRO in China: SWOT Analysis and Development Strategies

亚洲社会药学

CRO in China: SWOT Analysis and Development Strategies

Ding Ling, Dong Li*

School of Business Administration, Shenyang Pharmaceutical University, Shenyang 110016, China

出版日期:2018-09-20 发布日期:2018-11-13

CRO in China: SWOT Analysis and Development Strategies

Ding Ling, Dong Li*

School of Business Administration, Shenyang Pharmaceutical University, Shenyang 110016, China

Online:2018-09-20 Published:2018-11-13
Contact: Dong Li, associate professor and master tutor. Main research area: pharmaceutical intellectual property and international trade in medicine. Tel: 024-23986543, E-mail: sydongli@163.com.

摘要/Abstract

摘要： Objective To study the development trend and prospect of CRO in China. Methods Current status and existing problems of CRO development in China and abroad were analyzed by SWOT and suggestions were raised accordingly. Results and Conclusion Suggestions raised by SWOT analysis can provide reliable references for the development of CRO in China.

关键词: CRO, SWOT, development, countermeasure

Abstract: Objective To study the development trend and prospect of CRO in China. Methods Current status and existing problems of CRO development in China and abroad were analyzed by SWOT and suggestions were raised accordingly. Results and Conclusion Suggestions raised by SWOT analysis can provide reliable references for the development of CRO in China.

Key words: CRO, SWOT, development, countermeasure

Ding Ling, Dong Li. CRO in China: SWOT Analysis and Development Strategies[J]. 亚洲社会药学.

Ding Ling, Dong Li. CRO in China: SWOT Analysis and Development Strategies[J]. Asina Journal Of Social Pharmacy.

[1]	Xiao Yao, Sun Lihua. Analysis on Causes of Drug Shortages and Countermeasures[J]. 亚洲社会药学, 2021, 16(2): 108-113.
[2]	Wu Tong, Dong Li. Analysis on the Development Trend and Countermeasures of Clopidogrel [J]. 亚洲社会药学, 2021, 16(2): 139-144.
[3]	Sun Yinxiang, Xu Chunhua, Li Yong, Huang Sichao, Zhou Zhiling, Cui Min . The Practice of Pharmacist-Driven Antimicrobial Stewardship Based on Value-Based Healthcare[J]. 亚洲社会药学, 2021, 16(2): 180-186.
[4]	Wang Shuling, Shi Ping. Analysis on the Development Dilemma and Opportunity of Independent Clinical Laboratory Based on PEST-SWOT[J]. 亚洲社会药学, 2021, 16(1): 31-40.
[5]	Liu Tianchi, Zeng Yu. SWOT Analysis and Countermeasures Study on TCM Industry in Hainan Free Trade Port[J]. 亚洲社会药学, 2021, 16(1): 41-47.
[6]	Yin Yamin, Huang Zhe. Research on Development Strategy of Online Pharmacies Based on Blockchain Technology [J]. 亚洲社会药学, 2020, 15(4): 243-250.
[7]	Lv Xin, Chen Yuwen. SWOT Analysis of ARNI Anti-Heart Failure Drugs in Chinese Market[J]. 亚洲社会药学, 2020, 15(3): 139-144.
[8]	Cao Linlin, Wu Zhi’ang. Bibliometric Analysis of Drug Supply Chain in China[J]. 亚洲社会药学, 2020, 15(3): 159-170.
[9]	Gu Chi, Chen Yuwen. An Analysis of Marketing Trend of IVD in China[J]. 亚洲社会药学, 2020, 15(2): 83-88.
[10]	Wang Wanting, Xing Hua. Application Research of Earned Value Management in New Drug Research and Development Projects[J]. 亚洲社会药学, 2020, 15(1): 16-21.
[11]	Fu Geyang, Tian Lijuan. The Analysis of Marketing Strategy of Plendil[J]. 亚洲社会药学, 2020, 15(1): 37-43.
[12]	Zhi Yuanyuan, Wang Shuling. Comparative Study on the Development of Urban Basic Medical Insurance in 14 Cities of Liaoning Province[J]. 亚洲社会药学, 2020, 15(1): 44-56.
[13]	De Xianhui, An Lianyu, Wang Shuling. Development of Licensed Pharmacists in China: Dilemma and Opportunity[J]. 亚洲社会药学, 2019, 14(4): 192-203.
[14]	Shi Ping, Wang Shuling. Pharmaceutical WeChat Public Platform Based on PEST-SWOT Matrix Model: Current Status and Development Strategies [J]. 亚洲社会药学, 2019, 14(4): 209-218.
[15]	Zhang Xu, Tian Lijuan. Regulation of Drug Clinical Trials in China: Course and Development Trend[J]. 亚洲社会药学, 2019, 14(3): 87-91.

亚洲社会药学

CRO in China: SWOT Analysis and Development Strategies

CRO in China: SWOT Analysis and Development Strategies

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价